Rank: Guest
|
Posted By Phil Kitcher
I advise a Company who periodically have human tissue samples in their laboratories. They have appropriate procedures for containment, handling and disposal etc. Risk assessment has identified that a small outstanding risk of hepatitis (and other laboratory acquired infections) remain.
For laboratory Staff HVB (Hepatitis Virus B) inoculation is provided on a voluntary basis. As it happens all the current staff have taken this offer up.
The question is, what should be done should a member of staff decline?
Without digressing into the legal issues of Employer liability etc., a position of, “Fine on your own head be it – sign to say you are declining this offer.” has been the approach.
It has been suggested that any such staff member declining the inoculation should be excluded from working in the laboratory. Is this an appropriate reaction? Bear in mind the HBV is only one of the potential hazards present in human tissue samples, many of the other potential infections cannot be inoculated against. As it happens HVB has an easy and effective vaccine. My initial opinion is that exclusion from the laboratory is an excessive action. Better is to concentrate on the effective laboratory procedures (absence of sharps, housekeeping, containment, disinfection, sterilisation of waste, use of gloves etc. to reduce risk of infection from the samples. What do other members think?
|
|
|
|
Rank: Guest
|
Posted By Ron Hunter
And what of analphylactic reaction? Of contra-indicator symptoms and hypersensitivity?
Innoculation itself is not without risk. Are your people aware of these risks?
There are occupational health providers who would view innoculation as a very last resort.
What are the significant findings of your Risk Assessment?
|
|
|
|
Rank: Guest
|
Posted By John Richards
The current staff may well have taken the offered vaccine. Currently, at least a third of them will have not developed immunity from the vaccine, or will have not developed full immunity. (statistics)
|
|
|
|
Rank: Guest
|
Posted By Fred Pratley
Definitely not my area of expertise, but assuming the person declining the inoculation develops one of the various infections, does the person then present as a significant infection risk to work colleagues, bearing in minding your internal protocols and incubation periods etc?
If yes, a significant risk, then surely the inoculation programme needs to be mandatory?
Also, if the risk proves not to be significantly different, adopting an "exclusion from labs" policy could have potential lead to later claims of discrimination.
|
|
|
|
Rank: Guest
|
Posted By Ian Blenkharn
Quite unnecessary, though if the employer was offering vaccination from a reputable provider that can offer pre- and post-vaccine antibody screening that is commendable.
If lab procedures were sufficiently unsafe that a risk exists then the work must be stopped and vaccination against infection with just a single pathogen would be of itself grossly insufficient.
You may need a fresh pair of eyes to examine laboratory safety standards.
Not at all sure what on earth Mr Pratley imagines that we get up to in laboratories, that puts us at risk of person-to-person transmission of a bloodborne virus, but most of us spend the day working so there really is no problem!
If you need specific advise, feel free to get in touch.
Ian Blenkharn
|
|
|
|
Rank: Guest
|
Posted By jclamb
I would agree with your approach re not making it mandatory. There are many reasons why someone might refuse an immunisation, not least because they have an undisclosed underlying health reason (that may not have any effect on their ability to work) which makes them unable to have it, for example they may be immnosuppressed. A point worth considering re potential discrimination issues.
|
|
|
|
Rank: Guest
|
Posted By Peter F.
Could making it mandatory be against someones Human rights?
|
|
|
|
Rank: Guest
|
Posted By Tanya Boyce
Are the tissue samples screened, partly screened or completley untested when they arrive with you? this information will likely change the risk assessment outcome.
All our human tissue workers are given HepB vaccines by occ health. If there is an issue with someone not wanting to have the vaccine or not being able to have it then it is reffered to occ health to find out why and advise us. If someone cant have it due to immunosuppression then it raises a good question over how safe it is to work in lab with potentail pathogen containing samples. Further assessment is then needed.
|
|
|
|
Rank: Guest
|
Posted By John Richards
And what about the 10% + who do not develop immunity to Hep_B in spite of the inoculations ?
Not to mention those who only display a weak immune response ?
Another course of injections ?
|
|
|
|
Rank: Guest
|
|
|
|
|
Rank: Guest
|
Posted By John Richards
Been around for a while. The interesting bits start at 81....
81
Under RIDDOR, you must report infections and dangerous occurrences with biological agents at work. Examples of dangerous occurrences include an accident or an incident arising out of the work, which could result in the release of a biological agent likely to cause severe human illness or infection, or a sharps injury involving a high risk patient. In addition, local records should be kept of all such incidents and the underlying cause(s) should be investigated and noted. Other voluntary reporting and surveillance schemes exist.
|
|
|
|
Rank: Guest
|
Posted By Phil Kitcher
Thank you all so far for the responses.
Ron Hunter correctly gives a reason for why the HBV immunisation may be refused. (for example: The individual has previously had an allergic reaction to this vaccine or has a severe allergic reaction to yeast(used in the manufacturing process for the vaccine).) Thus it is possible to countenance valid reasons not to vaccinate.
Some of the tissue samples we have in the laboratories are HBV positive. They are contained and and handled in a manner consistent with HSE guidance on blood borne pathogens (see Jim Tassell link). The Employer does offer the vaccination from a reputable supplier, (pre-screen, then a course of 3 injections followed by post screening) together with periodic boosters as given to health care workers in much higher risk environments. (blood transfusion units).
For Ian Blenkham: I am reasonably confident the laboratory safety standards are sufficiently robust to prevent infection. However probability for these events is not zero. I side benefit of the voluntary policy is that Staff gain an immunity with only slight discomfort to themselves and the employer is indirectly protected from claims should the disease be caught elsewhere.
Re-reading http://www.hse.gov.uk/biosafety/diseases/bbv.pdf I notice para 119.
“ Employees are at liberty to refuse vaccination, but any refusal should be considered as part of the risk assessment – since additional controls may be necessary - and considered with regards to the type of work assigned to the individual."
Currently there is a policy of excluding immuno-suppressed individuals from working in these Labs.
From the discussion I think I am on the right track. It is appropriate for the vaccination to be voluntary since our work is not of high(est) risk for the pathogen.
Phil
|
|
|
|
You cannot post new topics in this forum.
You cannot reply to topics in this forum.
You cannot delete your posts in this forum.
You cannot edit your posts in this forum.
You cannot create polls in this forum.
You cannot vote in polls in this forum.